Skip to main content
. 2023 Jan 25;50(8):S57–S63. doi: 10.1097/OLQ.0000000000001776

TABLE 3.

Fast Track Partner Services Clients Program Utilization

Fast Track 1.0 (n = 12) March to December 2019 Fast Track 2.0 (n = 23) August 2020 to March 2021
n %* % n %* %
NP telehealth visit 12 100% 100% 21 91% 91%
HIV testing
Tested for HIV 12 100% 100% 18 86% 78%
 Positive result 1 8% 8% 3 17% 13%
 Negative result 11 92% 92% 15 83% 65%
Interested in HTK 10 48% 43%
 Used HTK 2 20% 9%
PrEP services cascade
 Educated about PrEP 12 100% 100% 21 100% 91%
 Interested in or referred for PrEP 10 91% 83% 18 86% 78%
 Received starter packs in field 5 50% 42%
 Started PrEP 4 40%§ 33% 10 59%§ 43%
 Scheduled refill appointment 3 75% 25% 8 80% 35%
 Refill appointment confirmed 1 33% 8% 4 50% 17%
PEP services cascade
 Eligible 2 18% 17% 3 20% 13%
 Accepted and completed 1 50% 8% 2 67% 9%
 PEP to PrEP 0 0% 0% 2 100% 9%
Linkage to Care
Newly Diagnosed 1 8% 8% 3 17% 13%
 Started ART (total) 1 100% 8% 1 33% 4%
 Immediate start ART 1 100% 8% 2 67% 9%
 Confirmed linkage to care 1 100% 8% 3 100% 13%
STI testing and treatment
 Tested for GC/CT 12 100% 100% 13 100% 57%
  Positive 2 17% 17% 3 23% 13%
  Treated 2 100% 17% 3 100% 13%
 Tested for syphilis 7 58% 58% 13 100% 57%
  Positive 2 29% 17% 0 0% 0%
  Treated 2 100% 17% N/A N/A N/A

NOTE: Percentages should be interpreted with caution, given the small sample size.

*Percentage among relevant subgroup of patients.

Percentage among all.

Interested in PrEP, among those who tested HIV-negative in the field, for FT 1.0. Referred for PrEP, among all, for FT 2.0. This is due to HIV testing being performed at a separate in-person visit, after initial phone-based PrEP referral services.

§Among those interested in starting PrEP, for FT 1.0. For FT 2.0, the denominator excludes 1 person who was referred for PrEP but then tested HIV-positive and initiated immediate start ART.

Among those who tested HIV negative.

STI testing among all in FT 1.0 and among those who came to an NYC SHC in FT 2.0 (n = 13).